Image

Using Shared Decision Making to Improve Family Media Use Planning

Using Shared Decision Making to Improve Family Media Use Planning

Recruiting
11 years and older
All
Phase N/A

Powered by AI

Overview

Investigators will conduct a pilot randomized controlled trial assessing the efficacy and feasibility of the newly developed Media Discussion and Planning Tool (MDPT).

Description

The clinical trial portion of this study will enroll 150 families (child age 11-17, and at least one parent/guardian) with demographic quotas to construct a sampling frame that is nationally representative in terms of race/ethnicity, parent education and income. Stratified randomization will be used to assign families to the intervention (MDPT) or control (delayed MDPT) condition. Families assigned to the intervention condition will be asked to complete the MDPT within 2 weeks of randomization and will be sent a second survey one week after plan completion. Participants in the control condition will complete a condition-specific subset of these questions three weeks after baseline. Participants in both conditions will complete a follow-up survey assessing media use and health behaviors two months after their second survey.

The primary outcomes will be change in adolescent and parent media use practices, and key mediators will be core components of shared decision making process (i.e., informed, clear on values, engaged in planning and decision making), implementation readiness (i.e., self-efficacy) and within-family communication. Two-month follow-up surveys will provide preliminary data about maintenance of behavioral changes.

Eligibility

Inclusion Criteria:

  • Children between the ages of 11 and 17
  • Parent/guardian of a child between the ages of 11 and 17
  • English speaking

Exclusion Criteria:

  • Parent/guardian or child does not want to participate (i.e., dyads only)
  • Non-English speaking

Study details
    Adolescent Behavior

NCT05722535

Seattle Children's Hospital

19 May 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.